A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Nuclear Imaging Institute
First Hospital of China Medical University
University of California, San Francisco
University of California, San Francisco
Vanderbilt-Ingram Cancer Center
UNC Lineberger Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Nuclear Imaging Institute
University of Utah
Stanford University
National Cancer Institute (NCI)
Queen Mary University of London
University of Southern California
University of Utah
Stanford University
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Avid Radiopharmaceuticals
Case Comprehensive Cancer Center
Emory University
University Hospitals of North Midlands NHS Trust
Memorial Sloan Kettering Cancer Center
Stanford University
University College London Hospitals
University Hospitals Bristol and Weston NHS Foundation Trust
University Health Network, Toronto
National Cancer Institute (NCI)
Ontario Clinical Oncology Group (OCOG)
Ontario Clinical Oncology Group (OCOG)